Literature DB >> 15843556

Human NK cells lyse organ-specific endothelial cells: analysis of adhesion and cytotoxic mechanisms.

Aleksandra Bielawska-Pohl1, Claire Crola, Anne Caignard, Catherine Gaudin, Danuta Dus, Claudine Kieda, Salem Chouaib.   

Abstract

Human organ-specific microvascular endothelial cells (ECs) were established and used in the present study to investigate their susceptibility to natural killer cell line (NKL)-induced lysis. Our data indicate that although IL-2-stimulated NKL (NKL2) cells adhered to the human peripheral (HPLNEC.B3), mesenteric lymph node (HMLNEC), brain (HBrMEC), and lung (HLMEC) and skin (HSkMEC.2) ECs, they significantly killed these cells quite differently. A more pronounced lysis of OSECs was also observed when IL-2-stimulated, purified peripheral blood NK cells were used as effector cells. In line with the correlation observed between adhesion pattern and the susceptibility to NKL2-mediated killing, we demonstrated using different chelators that the necessary adhesion step was governed by an Mg(2+)-dependent, but Ca(2+)-independent, mechanism as opposed to the subsequent Ca(2+)-dependent killing. To identify the cytotoxic pathway used by NKL2 cells, the involvement of the classical and alternate pathways was examined. Blocking of the Ca(2+)-dependent cytotoxicity pathway by EGTA/MgCl(2) significantly inhibited endothelial target cell killing, suggesting a predominant role for the perforin/granzyme pathway. Furthermore, using confocal microscopy, we demonstrated that the interaction between NKL2 effectors and ECs induced cytochrome c release and Bid translocation in target cells, indicating an involvement of the mitochondrial pathway in NKL2-induced EC death. In addition, although all tested cells were sensitive to the cytotoxic action of TNF, no susceptibility to TRAIL or anti-Fas mAb was observed. The present studies emphasize that human NK cell cytotoxicity toward ECs may be a potential target to block vascular injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843556     DOI: 10.4049/jimmunol.174.9.5573

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Selective human endothelial cell activation by chemokines as a guide to cell homing.

Authors:  Claire Crola Da Silva; Nathalie Lamerant-Fayel; Maria Paprocka; Michèle Mitterrand; David Gosset; Danuta Dus; Claudine Kieda
Journal:  Immunology       Date:  2008-09-16       Impact factor: 7.397

Review 2.  Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes.

Authors:  Claude A Piantadosi; Hagir B Suliman
Journal:  Biochim Biophys Acta       Date:  2012-01-14

3.  The anti-angiogenic activity of IL-12 is increased in iNOS-/- mice and involves NK cells.

Authors:  Aleksandra Bielawska-Pohl; Séverine Blesson; Houssem Benlalam; Aurélie Trenado; Paule Opolon; Olivia Bawa; Valérie Rouffiac; Danuta Dus; Claudine Kieda; Salem Chouaib
Journal:  J Mol Med (Berl)       Date:  2010-04-11       Impact factor: 4.599

Review 4.  Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation.

Authors:  Olaf Hoffmann; Frauke Zipp; Joerg R Weber
Journal:  J Mol Med (Berl)       Date:  2009-05-17       Impact factor: 4.599

5.  Irradiation-induced up-regulation of HLA-E on macrovascular endothelial cells confers protection against killing by activated natural killer cells.

Authors:  Isabelle Riederer; Wolfgang Sievert; Günther Eissner; Michael Molls; Gabriele Multhoff
Journal:  PLoS One       Date:  2010-12-16       Impact factor: 3.240

6.  Lipopolysaccharide and interferon-gamma enhance Fas-mediated cell death in mouse vascular endothelial cells via augmentation of Fas expression.

Authors:  N Koide; A Morikawa; G Tumurkhuu; J Dagvadorj; F Hassan; S Islam; Y Naiki; I Mori; T Yoshida; T Yokochi
Journal:  Clin Exp Immunol       Date:  2007-09-27       Impact factor: 4.330

7.  Vaccines targeting the neovasculature of tumors.

Authors:  Agata Matejuk; Qixin Leng; Szu-Ting Chou; Archibald J Mixson
Journal:  Vasc Cell       Date:  2011-03-08

8.  Ribosomal and immune transcripts associate with relapse in acquired ADAMTS13-deficient thrombotic thrombocytopenic purpura.

Authors:  Contessa E Edgar; Deirdra R Terrell; Sara K Vesely; Jonathan D Wren; Igor M Dozmorov; Timothy B Niewold; Michael Brown; Fang Zhou; Mark Barton Frank; Joan T Merrill; Johanna A Kremer Hovinga; Bernhard Lämmle; Judith A James; James N George; A Darise Farris
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

9.  Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization.

Authors:  Anna Tejchman; Nathalie Lamerant-Fayel; Jean-Claude Jacquinet; Aleksandra Bielawska-Pohl; Katarzyna Mleczko-Sanecka; Catherine Grillon; Salem Chouaib; Maciej Ugorski; Claudine Kieda
Journal:  Oncotarget       Date:  2017-05-09

Review 10.  The role of hypoxia in shaping the recruitment of proangiogenic and immunosuppressive cells in the tumor microenvironment.

Authors:  Salem Chouaib; Viktor Umansky; Claudine Kieda
Journal:  Contemp Oncol (Pozn)       Date:  2018-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.